MOSAIC IMMUNOENGINEERING, INC.

Highlights Mosaic ImmunoEngineering, Inc.

Equities

CPMV

US61945M1018

Market Closed - OTC Markets Other stock markets 12:24:49 14/06/2024 am IST			5-day change	1st Jan Change
0.55 ^USD	0.00%		0.00%	-8.33%

14/05	Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
19/04	Mosaic Immunoengineering, Inc. Announces Demise of Gloria Felcyn, Independent Director and Member of Audit Committee, Compensation Committee and Corporate Governance and Nominating Committee	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04	CI
Mosaic ImmunoEngineering, Inc. Receives Letter of Termination from CWRU	29/03	CI
Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02/11	CI
Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/23/04	CI
Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Mosaic ImmunoEngineering Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	03/23/03	CI
Mosaic ImmunoEngineering Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	01/22/01	CI
Mosaic ImmunoEngineering Inc. Academic Collaborators Receives Grants Totaling $4.3 Million from NCI Focuses on its Novel Immuno-Oncology Platform	31/22/31	CI
Mosaic ImmunoEngineering Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	04/22/04	CI
Mosaic ImmunoEngineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	10/22/10	CI
Mosaic ImmunoEngineering Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	26/22/26	CI
Mosaic Immunoengineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	05/21/05	CI
Reverse Split: 1 of 500	02/20/02	FA
Mosaic ImmunoEngineering Inc acquired Patriot Scientific Corporation for $30.3 million in a reverse merger transaction.	24/20/24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer